ACT - アカシア・リサ―チ (AdvisorShares Vice ETF) アカシア・リサ―チ



symbol ACT
会社名 Acacia Research Corp (アカシア・リサ―チ)
業種    金融(Financials)
概要 事業概要 --   アカシア・リサ―チは米国の特許取得・ライセンス企業。主に特許権の取得、ライセンス供与・維持・管理に従事する。特許者の特許出願、保護、ライセンス供与、訴訟を支援。また、経営不振企業やベンチャ―企業とパ―トナ―となり、特許を取得するほか、米国内外の特許権を買い取る。181件の特許権を所有、管理する。本社はカリフォルニア州。   
本社所在地 520 Newport Center Drive 12th Floor Newport Beach CA 92660 USA
設立年月日 33970
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 13人
終値(lastsale) 27.0698
時価総額(marketcap) 14888390
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --



   IP : Actual Experience plc - Board Changes | MarketScreener  2019/12/04 12:19:15 MarketScreener
Actual Experience plc , the analytics-as-a-service company, is pleased to announce the following changes to its Board. Kirsten English will join the Board as… | December 4, 2019
   Actual Experience : Board Changes | MarketScreener  2019/12/04 07:28:18 MarketScreener
4 December 2019 Actual Experience plc Board Changes Actual Experience plc , the analytics-as-a-service… | December 4, 2019
   RedHill Biopharma Appoints Dr. June Almenoff as Chief Scientific Officer  2019/05/28 11:00:00 Benzinga
TEL-AVIV, Israel and RALEIGH, N.C., May 28, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL ) (Tel-Aviv Stock Exchange: RDHL ) ("RedHill" or the "Company"), a specialty biopharmaceutical company primarily focused on gastrointestinal diseases, today announced the appointment of Dr. June S. Almenoff, M.D., Ph.D., FACP, as Chief Scientific Officer. Dr. Almenoff, an accomplished pharma executive with extensive gastroenterology and infectious diseases expertise, will lead the Company's commercial strategy as it relates to medical and scientific matters, including the medical affairs activities for Talicia ® (RHB-105) 1 in preparation for potential U.S. commercial launch in the fourth quarter of 2019. In addition, Dr. Almenoff will oversee the clinical development of RHB-204 for pulmonary nontuberculous mycobacteria (NTM) infections and the pivotal Phase 3 study planned to be initiated in the second half of 2019. With over 20 years of experience in the pharmaceutical industry, Dr.
   AdvisorShares Launches Pure Cannabis ETF (Ticker: YOLO)  2019-04-16 PR Newswire
BETHESDA, Md. , April 16, 2019 /PRNewswire/ --AdvisorShares, a leading sponsor of actively managed exchange-traded funds (ETFs), announced today that the AdvisorShares Pure Cannabis ETF (Ticker: YOLO) will begin trading on Thursday, April 18, 2019 . YOLO becomes the first U.S.-li…

 関連キーワード  (― 米国株 アカシア・リサ―チ ACT AdvisorShares Vice ETF)

 twitter  (公式ツイッターやCEOツイッターなど)